Back

drs. L.M. van der Oost

drs. L.M. van der Oost

Professor Emeritus

Show full profile

Research Output (555)

Estimated life expectancy without recurrent cardiovascular events in patients with vascular disease:The SMART-REACH model

Kaasenbrood Lotte, Bhatt Deepak L., Dorresteijn Jannick A.N., Wilson Peter W.F., D’Agostino Ralph B., Massaro Joseph M., van der Graaf Yolanda, Cramer Maarten J.M., Kappelle L. Jaap, de Borst Gert J., Steg Ph Gabriel, Visseren Frank L.J. 1 Aug 2018, In: Journal of the American Heart Association. 7

Prevalence of subclinical coronary artery disease assessed by coronary computed tomography angiography in 45- to 55-year- old women with a history of preeclampsia

Zoet Gerbrand A., Benschop Laura, Boersma Eric, Budde Ricardo P.J., Fauser Bart C.J.M., Van Der Graaf Yolanda, De Groot Christianne J.M., Maas Angela H.E.M., Roeters Van Lennep Jeanine E., Steegers Eric A.P., Visseren Frank L., Van Rijn Bas B., Velthuis Birgitta K., Franx Arie, Appelman Yolande E., Baart Sara J., Brouwers Laura, Cannegieter Suzanne C., Dam Veerle, Eijkemans M. C.J., Ferrari Michel D., Gunning Marlise N., Hoek Annemieke, Koffijberg Erik, Koster M. P.H., Kruit Mark, Lagerwij Giske R., Lambalk C. B., Laven Joop S., Linstra Katie, Van Der Lugt Aad, Van Den Brink Antoinette Maassen, Meun Cindy, Middeldorp Saskia, Moons Karel G.M., Roos-Hesselink Jolien W., Scheres Luuk J.J., Steegers-Theunissen Regine P.M., Terwindt Gisela M., Wermer Marieke J.H., 20 Feb 2018, In: Circulation. 137 , p. 877-879 3 p.

Thyroid-stimulating hormone levels in the normal range and incident type 2 diabetes mellitus

de Vries T. I., Kappelle L. J., van der Graaf Y., de Valk H. W., de Borst G. J., Nathoe H. M., Visseren F. L.J., Westerink Jan, 1 Jan 2018, In: Acta Diabetologica. 56 , p. 431-440 10 p.

Limited benefit of haemoglobin glycation index as risk factor for cardiovascular disease in type 2 diabetes patients

Østergaard H. B., Mandrup-Poulsen T., Berkelmans G. F.N., van der Graaf Y., Visseren F. L.J., Westerink J., 1 Jan 2018, In: Diabetes and Metabolism. 45 , p. 254-260 7 p.

Identification of vascular patients at very high risk for recurrent cardiovascular events:Validation of the current ACC/AHA very high risk criteria

Van Den Berg M. Johanneke, Bhatt Deepak L., Kappelle L. J., De Borst Gert J., Cramer Maarten J., Van Der Graaf Yolanda, Steg Ph Gabriel, Visseren Frank L.J., Algra A., Van Der Graaf Yolanda, Grobbee D. E., Rutten G. E.H.M., Visseren Frank L.J., , , De Borst Gert J., Kappelle L. J., Leiner T., Nathoe H. M. 1 Jan 2017, In: European Heart Journal. 38 , p. 3211-3218 8 p.

Personalized absolute benefit of statin treatment for primary or secondary prevention of vascular disease in individual elderly patients

Stam-Slob Manon C., Visseren Frank L J, Wouter Jukema J., van der Graaf Yolanda, Poulter Neil R., Gupta Ajay, Sattar Naveed, Macfarlane Peter W., Kearney Patricia M., de Craen Anton J M, Trompet Stella 1 Jan 2017, In: Clinical Research in Cardiology. 106 , p. 58-68 11 p.

Hippocampal volume and the course of depressive symptoms over eight years of follow-up

Buddeke J, Kooistra M, Zuithoff N P A, Gerritsen L, Biessels G J, van der Graaf Y, Geerlings M I, Jan 2017, In: Acta Psychiatrica Scandinavica. 135 , p. 78-86 9 p.

Distribution of Estimated 10-Year Risk of Recurrent Vascular Events and Residual Risk in a Secondary Prevention Population

Kaasenbrood Lotte, Boekholdt S. Matthijs, Van Der Graaf Yolanda, Ray Kausik K., Peters Ron J G, Kastelein John J P, Amarenco Pierre, Larosa John C., Cramer Maarten J M, Westerink Jan, Kappelle L. Jaap, De Borst Gert J., Visseren Frank L J 8 Nov 2016, In: Circulation. 134 , p. 1419-1429 11 p.

Metabolic consequences of adipose tissue dysfunction and not adiposity per se increase the risk of cardiovascular events and mortality in patients with type 2 diabetes

Franssens Bas T. , Westerink Jan, van der Graaf Yolanda, Nathoe Hendrik M., Visseren Frank L J 1 Nov 2016, In: International Journal of Cardiology. 222 , p. 72-77 6 p.

Individualized prediction of the effect of angiotensin receptor blockade on renal and cardiovascular outcomes in patients with diabetic nephropathy.

van der Sande NGC, Dorresteijn JAN, Visseren FLJ, Dwyer J.P., Blankestijn p, van der Graaf Y, Heerspink H. J Lambers Nov 2016, In: Diabetes, Obesity & Metabolism. 18 , p. 1120-1127

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not